M84.56 Pathological fracture in neoplastic disease, tibia and fibula

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Tibia and Fibula (ICD-10-CM: M84.56)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the tibia and fibula. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the integrity of these lower leg bones, which may involve primary bone tumors or metastatic spread to the tibia/fibula region.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the tibia and fibula, compromising their structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode these bones, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the tibia or fibula.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to lower leg sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the fracture site, often without obvious injury.
• Swelling, bruising, or visible deformity in the affected lower leg.
• Difficulty bearing weight or limited mobility of the ankle/foot.
• Possible instability or abnormal movement of the leg.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and correlation with cancer history. X-rays or CT scans typically reveal a fracture in the tibia/fibula with underlying bone abnormalities (e.g., lytic lesions, tumor infiltration). Bone scans or MRI may identify additional metastatic sites or assess tumor extent. Biopsy of the fracture site or adjacent bone may confirm neoplastic involvement, especially if the primary cancer source is unknown.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options may include immobilization (casting, bracing), surgical fixation (plates, rods, or intramedullary nails), or radiation therapy to reduce tumor burden and strengthen bone. Systemic cancer treatments (chemotherapy, targeted therapy) may also be used to control the primary malignancy. Pain management and rehabilitation are integral to recovery.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer, as well as the fracture’s impact on function. Stable fractures with controlled cancer may have better outcomes, while aggressive tumors or multiple fractures can complicate recovery. Follow-up includes regular imaging to monitor healing and tumor activity, as well as assessments for functional recovery and potential recurrence.

Complications

• Delayed or nonunion of the fracture due to ongoing tumor activity.
• Infection, especially with surgical intervention.
• Nerve or vascular damage from the fracture or treatment.
• Progression of the underlying cancer, leading to additional fractures.
• Chronic pain or mobility limitations.

Lifestyle & Prevention

• Avoid high-impact activities that stress the lower legs.
• Use assistive devices (crutches, walkers) to reduce weight-bearing stress.
• Maintain bone health through nutrition (calcium, vitamin D) if appropriate.
• Follow cancer treatment plans to control tumor growth.
• Report new or worsening pain promptly to healthcare providers.

When to Seek Professional Help

Seek immediate medical attention for:

• Sudden, severe pain in the lower leg without injury.
• Visible deformity, swelling, or inability to bear weight.
• Signs of infection (redness, warmth, fever) at the fracture site.
• New or worsening neurological symptoms (numbness, weakness) in the foot/ankle.

Tips for Medical Coders

Document the fracture site (tibia and fibula) and confirm the underlying neoplastic disease. Include details on the cancer type (primary or metastatic) and any contributing factors (e.g., radiation therapy) to support code assignment. Ensure the fracture is clearly linked to the neoplastic process, as this distinguishes it from traumatic fractures.